Language:
English
繁體中文
Help
圖資館首頁
Login
Back
Switch To:
Labeled
|
MARC Mode
|
ISBD
Druggable lipid signaling pathways
~
Kihara, Yasuyuki.
Druggable lipid signaling pathways
Record Type:
Electronic resources : Monograph/item
Title/Author:
Druggable lipid signaling pathwaysedited by Yasuyuki Kihara.
other author:
Kihara, Yasuyuki.
Published:
Cham :Springer International Publishing :2020.
Description:
vi, 260 p. :ill., digital ;24 cm.
Contained By:
Springer Nature eBook
Subject:
Lipids.
Online resource:
https://doi.org/10.1007/978-3-030-50621-6
ISBN:
9783030506216$q(electronic bk.)
Druggable lipid signaling pathways
Druggable lipid signaling pathways
[electronic resource] /edited by Yasuyuki Kihara. - Cham :Springer International Publishing :2020. - vi, 260 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology,v.12740065-2598 ;. - Advances in experimental medicine and biology ;946..
Preface -- Introduction of Druggable Lipid Signaling Pathway -- Biosynthetic Enzymes of Membrane Glycerophospholipid Diversity as Therapeutic Targets for Drug Development -- Druggable Prostanoid Pathway -- Targeting Leukotrienes as a Therapeutic Strategy to Prevent Comorbidities Associated with Metabolic Stress -- Epoxy Fatty Acids are Promising Targets for Treatment of Pain, Cardiovascular Disease and Other Indications Characterized by Mitochondrial Dysfunction, Endoplasmic Stress and Inflammation -- Druggable Sphingolipid Pathway -- Druggable Lysophospholipid Pathway -- Druggable targets in endocannabinoid signaling -- Drugging the phosphoinositide 3-kinase (PI3K) and phosphatidylinositol 4-kinase (PI4K) family of enzymes for treatment of cancer, immune disorders, and viral/parasitic infections -- Druggable Lipid GPCRs: Past, Present, and Prospects.
This edited work presents a series of reviews focusing on Druggable Lipid Signaling Pathways. It enables researchers in both academic institutions and industry as well as physicians to understand historical aspects of lipid signaling and future directions of drug discovery targeting lipid signaling pathways. This book provides 9 pathways including acyltransferases, prostanoids, leukotrienes, epoxy fatty acids, sphingolipids, lysophospholipids, endocannabinoids, phosphoinositides, and lipid GPCRs. Readers will discover the importance of each lipid signaling pathway that contributes to broad range of diseases including neurological and neuropsychiatric diseases, pain, metabolic syndromes, cardiovascular diseases, cancer, dermatological diseases, fibrosis, inflammation, etc. Also, readers will recognize that many drugs targeting lipid signaling have been clinically used. Drugs currently under development are also discussed in each chapter, which includes some information about clinical trials and strategic drug designs.
ISBN: 9783030506216$q(electronic bk.)
Standard No.: 10.1007/978-3-030-50621-6doiSubjects--Topical Terms:
197421
Lipids.
LC Class. No.: QP751 / .D784 2020
Dewey Class. No.: 612.01577
Druggable lipid signaling pathways
LDR
:02980nmm a2200349 a 4500
001
585762
003
DE-He213
005
20201231092236.0
006
m d
007
cr nn 008maaau
008
210323s2020 sz s 0 eng d
020
$a
9783030506216$q(electronic bk.)
020
$a
9783030506209$q(paper)
024
7
$a
10.1007/978-3-030-50621-6
$2
doi
035
$a
978-3-030-50621-6
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
QP751
$b
.D784 2020
072
7
$a
MBGR
$2
bicssc
072
7
$a
SCI049000
$2
bisacsh
072
7
$a
MBGR
$2
thema
072
7
$a
PSD
$2
thema
082
0 4
$a
612.01577
$2
23
090
$a
QP751
$b
.D794 2020
245
0 0
$a
Druggable lipid signaling pathways
$h
[electronic resource] /
$c
edited by Yasuyuki Kihara.
260
$a
Cham :
$b
Springer International Publishing :
$b
Imprint: Springer,
$c
2020.
300
$a
vi, 260 p. :
$b
ill., digital ;
$c
24 cm.
490
1
$a
Advances in experimental medicine and biology,
$x
0065-2598 ;
$v
v.1274
505
0
$a
Preface -- Introduction of Druggable Lipid Signaling Pathway -- Biosynthetic Enzymes of Membrane Glycerophospholipid Diversity as Therapeutic Targets for Drug Development -- Druggable Prostanoid Pathway -- Targeting Leukotrienes as a Therapeutic Strategy to Prevent Comorbidities Associated with Metabolic Stress -- Epoxy Fatty Acids are Promising Targets for Treatment of Pain, Cardiovascular Disease and Other Indications Characterized by Mitochondrial Dysfunction, Endoplasmic Stress and Inflammation -- Druggable Sphingolipid Pathway -- Druggable Lysophospholipid Pathway -- Druggable targets in endocannabinoid signaling -- Drugging the phosphoinositide 3-kinase (PI3K) and phosphatidylinositol 4-kinase (PI4K) family of enzymes for treatment of cancer, immune disorders, and viral/parasitic infections -- Druggable Lipid GPCRs: Past, Present, and Prospects.
520
$a
This edited work presents a series of reviews focusing on Druggable Lipid Signaling Pathways. It enables researchers in both academic institutions and industry as well as physicians to understand historical aspects of lipid signaling and future directions of drug discovery targeting lipid signaling pathways. This book provides 9 pathways including acyltransferases, prostanoids, leukotrienes, epoxy fatty acids, sphingolipids, lysophospholipids, endocannabinoids, phosphoinositides, and lipid GPCRs. Readers will discover the importance of each lipid signaling pathway that contributes to broad range of diseases including neurological and neuropsychiatric diseases, pain, metabolic syndromes, cardiovascular diseases, cancer, dermatological diseases, fibrosis, inflammation, etc. Also, readers will recognize that many drugs targeting lipid signaling have been clinically used. Drugs currently under development are also discussed in each chapter, which includes some information about clinical trials and strategic drug designs.
650
0
$a
Lipids.
$3
197421
650
0
$a
Cellular signal transduction.
$3
188626
650
0
$a
Pharmacology.
$3
218135
650
0
$a
Molecular biology.
$3
188737
650
0
$a
Diagnosis, Laboratory.
$3
265458
650
0
$a
Human genetics.
$3
192904
650
0
$a
Cancer
$x
Research.
$3
341951
650
1 4
$a
Molecular Medicine.
$3
273932
650
2 4
$a
Pharmacology/Toxicology.
$3
273652
650
2 4
$a
Laboratory Medicine.
$3
276727
650
2 4
$a
Human Genetics.
$3
273658
650
2 4
$a
Cancer Research.
$3
273660
650
2 4
$a
Lipidology.
$3
286297
700
1
$a
Kihara, Yasuyuki.
$3
876982
710
2
$a
SpringerLink (Online service)
$3
273601
773
0
$t
Springer Nature eBook
830
0
$a
Advances in experimental medicine and biology ;
$v
946.
$3
557559
856
4 0
$u
https://doi.org/10.1007/978-3-030-50621-6
950
$a
Biomedical and Life Sciences (SpringerNature-11642)
based on 0 review(s)
ALL
電子館藏
Items
1 records • Pages 1 •
1
Inventory Number
Location Name
Item Class
Material type
Call number
Usage Class
Loan Status
No. of reservations
Opac note
Attachments
000000189579
電子館藏
1圖書
電子書
EB QP751 .D794 2020 2020
一般使用(Normal)
On shelf
0
1 records • Pages 1 •
1
Multimedia
Multimedia file
https://doi.org/10.1007/978-3-030-50621-6
Reviews
Add a review
and share your thoughts with other readers
Export
pickup library
Processing
...
Change password
Login